Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Daclatasvir
- Therapeutic area
- Anti-infectives
- Drug class
- Antivirals
- ATC
- J05
- Strength
- 60 mg
- Dosage form
- Tablet
- Pack
- 28's
- Registration no.
- 092158
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 7,766.11 to 8,009.97 (+3.1%) between 1 Jul 2024 and 1 Jul 2025 · 2 official price records · pack 28's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Daclawil 60 mg, 28's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/daclawil-60-mg-092158-28s-wilsons-pharmaceuticals/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 8,009.97 | 2025-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Current |
| PKR 7,766.11 | 2024-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 092158Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
